Have a feature idea you'd love to see implemented?
Let us know!
HCWB HCW Biologics Inc
Price (delayed)
$0.7096
Market cap
$26.84M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1
Enterprise value
$38.64M
Highlights
HCW Biologics's gross profit has soared by 97% YoY but it has decreased by 7% from the previous quarter
HCWB's revenue has surged by 97% year-on-year but it is down by 7% since the previous quarter
HCW Biologics's equity has plunged by 142% YoY and by 58% from the previous quarter
The company's debt has surged by 102% YoY and by 29% QoQ
Key stats
What are the main financial stats of HCWB
Market
Valuations
Earnings
Shares outstanding
37.82M
Market cap
$26.84M
Enterprise value
$38.64M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
23.69
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
34.11
Revenue
$1.13M
EBIT
-$36.95M
EBITDA
-$36.17M
Free cash flow
-$19.15M
Per share
Balance sheet
Liquidity
EPS
-$1
Free cash flow per share
-$0.51
Book value per share
-$0.26
Revenue per share
$0.03
TBVPS
$0.7
Total assets
$26.56M
Total liabilities
$36.53M
Debt
$12.8M
Equity
-$9.97M
Working capital
-$27.97M
Debt to equity
-1.28
Current ratio
0.07
Quick ratio
0.05
Net debt/EBITDA
-0.33
Margins
Efficiency
Dividend
EBITDA margin
-3,192.3%
Gross margin
100%
Net margin
-3,294.6%
Operating margin
-3,158.5%
Return on assets
-132.9%
Return on equity
-2,516.9%
Return on invested capital
-229.8%
Return on capital employed
N/A
Return on sales
-3,261%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HCWB stock price
How has the HCW Biologics stock price performed over time
Intraday
-25.08%
1 week
129.64%
1 month
32.36%
1 year
-34.9%
YTD
-42.31%
QTD
31.55%
Financial performance
How have HCW Biologics's revenue and profit performed over time
Revenue
$1.13M
Gross profit
$1.13M
Operating income
-$35.79M
Net income
-$37.33M
Gross margin
100%
Net margin
-3,294.6%
HCW Biologics's gross profit has soared by 97% YoY but it has decreased by 7% from the previous quarter
HCWB's revenue has surged by 97% year-on-year but it is down by 7% since the previous quarter
The net income has dropped by 89% year-on-year but it is up by 2.7% since the previous quarter
The operating income has dropped by 74% year-on-year but it has increased by 3.7% since the previous quarter
Growth
What is HCW Biologics's growth rate over time
Valuation
What is HCW Biologics stock price valuation
P/E
N/A
P/B
N/A
P/S
23.69
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
34.11
HCWB's EPS has dropped by 79% year-on-year but it is up by 3.8% since the previous quarter
HCW Biologics's equity has plunged by 142% YoY and by 58% from the previous quarter
HCWB's revenue has surged by 97% year-on-year but it is down by 7% since the previous quarter
HCWB's price to sales (P/S) is 45% less than its last 4 quarters average of 43.1
Efficiency
How efficient is HCW Biologics business performance
The ROA has shrunk by 179% YoY and by 5% QoQ
HCWB's return on invested capital is down by 23% since the previous quarter
HCWB's ROS is down by 4.6% since the previous quarter but it is up by 2.9% year-on-year
Dividends
What is HCWB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HCWB.
Financial health
How did HCW Biologics financials performed over time
HCWB's total assets is 27% smaller than its total liabilities
HCW Biologics's quick ratio has shrunk by 98% YoY and by 38% QoQ
The company's current ratio has shrunk by 97% YoY and by 30% QoQ
HCW Biologics's equity has plunged by 142% YoY and by 58% from the previous quarter
The company's debt has surged by 102% YoY and by 29% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.